Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for “Borderline Resectable” in the Field of Surgery for Hilar Cholangiocarcinoma
Crossref DOI link: https://doi.org/10.1007/s00268-018-04883-y
Published Online: 2018-12-07
Published Print: 2019-04-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matsuyama, Ryusei
Morioka, Daisuke
Mori, Ryutaro
Yabushita, Yasuhiro
Hiratani, Seigo
Ota, Yohei
Kumamoto, Takafumi
Endo, Itaru
Version of Record valid from 2018-12-07
Text and Data Mining valid from 2018-12-07
Article History
First Online: 7 December 2018